BIOEDGE

Biological EDGE

Buy Now

“Meticulous research. Penetrating analysis. A solid framework for change.”  — Dr. Michael J. Krentz

Biological EDGE

Biohacking Starts With NO

Buy Now

“I used to override my body. Now I listen. The difference is stunning.”— Michael Broder

Biohacking Starts With NO
Devices and Wearables

Devices and Wearables Library

Every article, presentation, spotlight, and news item we've tagged to Devices and Wearables.

AllLibraryArticlesPresentationsSpotlightsNews

Showing 25–34 of 34

Longevity.TechnologyMar 4, 2026

Turning your bed into a preventive health platform

Eight Sleep's Pod smart mattress uses continuous biometric monitoring during sleep—tracking heart rate, heart rate variability, and breathing patterns—to shift from reactive treatment to predictive intervention. The company's $1.5 billion valuation reflects a strategic thesis that sleep represents both a high-frequency measurement window and an actionable intervention point for longevity and early disease detection.

Longevity.TechnologyApr 2, 2026

SpectraCell packages longevity, early disease detection in one kit

SpectraCell's Baseline Nexus bundles four diagnostic tests—micronutrient status, lipoprotein particle profiling, telomere length, and MTHFR genotyping—into a single assessment designed to identify subclinical dysfunction before it progresses to clinical disease. The package reframes preventive diagnostics by measuring intracellular nutrient utilization and biological aging markers alongside conventional cardiovascular risk factors, enabling earlier intervention at the stage where metabolic and inflammatory processes are still modifiable.

Longevity.TechnologyFeb 6, 2026

Cognision launches cognision360 platform for CNS trial biomarkers

Cognision360 consolidates neurobiomarker data collection and analysis for CNS clinical trials through automated workflows and standardized integration of EEG, sleep, eye tracking, wearables, and cognitive assessments. The platform addresses fragmentation in multi-site studies and accelerates regulatory pathways by improving data integrity and reducing manual processing errors.

LT WireApr 17, 2026

Life Time rolls out SpiroFit metabolic testing to country clubs

Life Time is deploying SpiroFit, a cordless wearable metabolic testing system, across 190 clubs to measure VO2 max and fuel utilization during exercise. The technology generates personalized heart-rate training zones with lab-grade accuracy, enabling members to optimize training intensity and metabolic efficiency.

LT WireApr 22, 2026

Inbrain completes enrollment in first human graphene brain study

Inbrain Neuroelectronics completed enrollment of a first-in-human trial implanting graphene cortical interfaces in eight patients undergoing neurosurgical tumor resection, demonstrating favorable safety and high-resolution neural signal capture without device-related adverse events. This represents early validation of graphene-based brain-computer interfaces for clinical applications.

Longevity.TechnologyMar 4, 2026

Science Corp and Neurosoft unite to speed brain-computer care

A partnership between Science Corporation and Neurosoft Bioelectronics reduces brain-computer interface development costs from $75–100 million to under $5 million, accelerating clinical adoption of therapies for neurological conditions including epilepsy and tinnitus. For longevity practitioners, this infrastructure advancement enables faster restoration of neurological function and cognitive independence—essential dimensions of healthspan that outlive lifespan alone.

Longevity.TechnologyMar 3, 2026

Nanotech startup lands funding for continuous biosensing platform

Xsensio has secured $7 million in Series A funding to advance a wearable biosensing platform that continuously monitors multiple biomarkers in interstitial fluid, initially targeting early detection of organ dysfunction in acute care settings. Real-time access to biochemical data at the point of care represents a shift from periodic laboratory measurement to continuous physiological surveillance, with potential implications for earlier clinical intervention.

Longevity.TechnologyFeb 6, 2026

Designing therapies patients can live with

Light-activated photodynamic therapy for cutaneous T-cell lymphoma demonstrates a treatment design principle critical to chronic disease management: therapies must be engineered for decades of safe, repeatable use rather than optimized solely for efficacy. For conditions that persist across a lifespan, cumulative toxicity and patient burden become as clinically significant as the primary disease.

Longevity.TechnologyApr 23, 2026

AliveCor shrinks the ECG and speeds up diagnosis

AliveCor's Kardia 12L is a handheld, AI-assisted device that captures 12-lead ECG-quality cardiac data with simplified hardware and reduced setup time. The CE-marked system detects 35 cardiac conditions and reduces testing time by approximately one-third, extending hospital-grade diagnostic capacity into primary care, rural, and home settings.

Longevity.TechnologyFeb 25, 2026

YOU(th) lands funding for smartphone-based preventive health screening

YOU(th) has secured $4.5 million to advance a smartphone-based screening platform that analyzes facial video, voice, eye images, and movement patterns to assess over 50 digital biomarkers across multiple organ systems in under two minutes. The approach aims to reduce friction in preventive health screening by leveraging ubiquitous smartphone sensors to detect physiological and metabolic signals outside traditional clinical settings.